{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T02:25:12Z","timestamp":1772504712026,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800683"],"award-info":[{"award-number":["81800683"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800683"],"award-info":[{"award-number":["81800683"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["Diabetes Mellitus Research Fund Program II-05"],"award-info":[{"award-number":["Diabetes Mellitus Research Fund Program II-05"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National ministry of science and technology project","award":["2021YFC2501600"],"award-info":[{"award-number":["2021YFC2501600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To explore the prevalence and clinical significance of newly diagnosed diabetes mellitus (DM) in patients with primary aldosteronism (PA). Investigating the risk factors for cardiocerebrovascular disease (CCVD) will guide strategies for reducing CCVD in patients with PA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively included 729 PA patients without DM and conducted oral glucose tolerance tests.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that 15.0% of PA patients had newly diagnosed DM. The DM prevalence increased with elevated aldosterone levels [OR\u2009=\u20093.20 (1.77, 5.78), <jats:italic>P<\/jats:italic> value\u2009&lt;\u20090.001]. The rate of CCVD in newly diagnosed diabetic PA patients was higher than that in nondiabetic PA patients at diagnosis (11.9% vs. 5.0%, <jats:italic>P<\/jats:italic>\u2009=\u20090.005). Furthermore, multivariate logistic analysis revealed that HT duration [1.055 (1.002,1.111), <jats:italic>P<\/jats:italic>\u2009=\u20090.041] and newly diagnosed DM [2.600 (1.072,6.303), <jats:italic>P<\/jats:italic>\u2009=\u20090.034] were significantly associated with CCVD in PA patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The prevalence of newly diagnosed DM in PA patients was higher than that in the general population. Aldosterone level was an independent risk factor for DM not for CCVD. CCVD was correlated with longer HT duration and newly diagnosed DM. Therefore, it is crucial to screen DM at the diagnosis in PA patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-022-03095-8","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:40:23Z","timestamp":1659091223000},"page":"519-526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Newly diagnosed diabetes mellitus is a risk factor for cardiocerebrovascular events in primary aldosteronism"],"prefix":"10.1007","volume":"77","author":[{"given":"Cui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiran","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingwei","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"issue":"7","key":"3095_CR1","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1097\/HJH.0b013e328360ddf6","volume":"31","author":"X Sang","year":"2013","unstructured":"X. Sang, Y. Jiang, W. Wang, L. Yan, J. Zhao, Y. Peng, W. Gu, G. Chen, W. Liu, G. Ning, Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China. J. Hypertens. 31(7), 1465\u20131471 (2013). discussion 1471-1462","journal-title":"J. Hypertens."},{"issue":"14","key":"3095_CR2","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"S. Monticone, J. Burrello, D. Tizzani, C. Bertello, A. Viola, F. Buffolo, L. Gabetti, G. Mengozzi, T.A. Williams, F. Rabbia, F. Veglio, P. Mulatero, Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J. Am. Coll. Cardiol. 69(14), 1811\u20131820 (2017)","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"3095_CR3","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2013.168118","volume":"310","author":"Y Xu","year":"2013","unstructured":"Y. Xu, L. Wang, J. He, Y. Bi, M. Li, T. Wang, L. Wang, Y. Jiang, M. Dai, J. Lu, M. Xu, Y. Li, N. Hu, J. Li, S. Mi, C.S. Chen, G. Li, Y. Mu, J. Zhao, L. Kong, J. Chen, S. Lai, W. Wang, W. Zhao, G. Ning, China noncommunicable disease surveillance g. prevalence and control of diabetes in Chinese adults. JAMA 310(9), 948\u2013959 (2013)","journal-title":"JAMA"},{"key":"3095_CR4","doi-asserted-by":"crossref","unstructured":"T. Wang, J. Lu, Q. Su, Y. Chen, Y. Bi, Y. Mu, L. Chen, R. Hu, X. Tang, X. Yu, M. Li, M. Xu, Y. Xu, Z. Zhao, L. Yan, G. Qin, Q. Wan, G. Chen, M. Dai, D. Zhang, Z. Gao, G. Wang, F. Shen, Z. Luo, Y. Qin, L. Chen, Y. Huo, Q. Li, Z. Ye, Y. Zhang, C. Liu, Y. Wang, S. Wu, T. Yang, H. Deng, D. Li, S. Lai, Z.T. Bloomgarden, L. Shi, G. Ning, J. Zhao, W. Wang, Group C.S. Ideal cardiovascular health metrics and major cardiovascular events in patients with prediabetes and diabetes. JAMA Cardiol. 4(9), 874\u2013883 (2019)","DOI":"10.1001\/jamacardio.2019.2499"},{"key":"3095_CR5","doi-asserted-by":"crossref","unstructured":"A. Saiki, M. Otsuki, D. Tamada, T. Kitamura, I. Shimomura, I. Kurihara, T. Ichijo, Y. Takeda, T. Katabami, M. Tsuiki, N. Wada, T. Yanase, Y. Ogawa, J. Kawashima, M. Sone, N. Inagaki, T. Yoshimoto, R. Okamoto, K. Takahashi, H. Kobayashi, K. Tamura, K. Kamemura, K. Yamamoto, S. Izawa, M. Kakutani, M. Yamada, A. Tanabe, M. Naruse, Group J.J.S. Diabetes mellitus itself increases cardio-cerebrovascular risk and renal complications in primary aldosteronism. J. Clin. Endocrinol. Metab. 105(7), dgaa177 (2020)","DOI":"10.1210\/clinem\/dgaa177"},{"issue":"8","key":"3095_CR6","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1097\/HJH.0000000000001361","volume":"35","author":"VC Wu","year":"2017","unstructured":"V.C. Wu, S.J. Chueh, L. Chen, C.H. Chang, Y.H. Hu, Y.H. Lin, K.D. Wu, W.S. Yang, T.S. Group, Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years. J. Hypertens. 35(8), 1698\u20131708 (2017)","journal-title":"J. Hypertens."},{"issue":"9","key":"3095_CR7","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.2337\/dc07-0525","volume":"30","author":"G Colussi","year":"2007","unstructured":"G. Colussi, C. Catena, R. Lapenna, E. Nadalini, A. Chiuch, L.A. Sechi, Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diabetes Care 30(9), 2349\u20132354 (2007)","journal-title":"Diabetes Care"},{"issue":"1","key":"3095_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","volume":"25","author":"G Giacchetti","year":"2007","unstructured":"G. Giacchetti, V. Ronconi, F. Turchi, L. Agostinelli, F. Mantero, S. Rilli, M. Boscaro, Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J. Hypertens. 25(1), 177\u2013186 (2007)","journal-title":"J. Hypertens."},{"issue":"12","key":"3095_CR9","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1007\/s00268-015-3197-z","volume":"39","author":"M Kaga","year":"2015","unstructured":"M. Kaga, T. Utsumi, T. Tanaka, T. Kono, H. Nagano, K. Kawamura, N. Kamiya, T. Imamoto, N. Nihei, Y. Naya, H. Suzuki, T. Ichikawa, Risk of new-onset dyslipidemia after laparoscopic adrenalectomy in patients with primary aldosteronism. World J. Surg. 39(12), 2935\u20132940 (2015)","journal-title":"World J. Surg."},{"issue":"6","key":"3095_CR10","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1210\/jc.2012-3934","volume":"98","author":"E Fischer","year":"2013","unstructured":"E. Fischer, C. Adolf, A. Pallauf, C. Then, M. Bidlingmaier, F. Beuschlein, J. Seissler, M. Reincke, Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. J. Clin. Endocrinol. Metab. 98(6), 2513\u20132520 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"3095_CR11","doi-asserted-by":"publisher","first-page":"776","DOI":"10.7326\/0003-4819-150-11-200906020-00005","volume":"150","author":"JR Sowers","year":"2009","unstructured":"J.R. Sowers, A. Whaley-Connell, M. Epstein, Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann. Intern Med 150(11), 776\u2013783 (2009)","journal-title":"Ann. Intern Med"},{"issue":"1","key":"3095_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12020-016-0983-9","volume":"54","author":"C Adolf","year":"2016","unstructured":"C. Adolf, E. Asbach, A.S. Dietz, K. Lang, S. Hahner, M. Quinkler, L.C. Rump, M. Bidlingmaier, M. Treitl, R. Ladurner, F. Beuschlein, M. Reincke, Worsening of lipid metabolism after successful treatment of primary aldosteronism. Endocrine 54(1), 198\u2013205 (2016)","journal-title":"Endocrine"},{"issue":"11","key":"3095_CR13","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1210\/en.2013-1115","volume":"154","author":"HM Jin","year":"2013","unstructured":"H.M. Jin, D.C. Zhou, H.F. Gu, Q.Y. Qiao, S.K. Fu, X.L. Liu, Y. Pan, Antioxidant N-acetylcysteine protects pancreatic beta-cells against aldosterone-induced oxidative stress and apoptosis in female db\/db mice and insulin-producing MIN6 cells. Endocrinology 154(11), 4068\u20134077 (2013)","journal-title":"Endocrinology"},{"issue":"8","key":"3095_CR14","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1210\/jc.2019-00299","volume":"104","author":"J Gerards","year":"2019","unstructured":"J. Gerards, D.A. Heinrich, C. Adolf, C. Meisinger, W. Rathmann, L. Sturm, N. Nirschl, M. Bidlingmaier, F. Beuschlein, B. Thorand, A. Peters, M. Reincke, M. Roden, M. Quinkler, Impaired glucose metabolism in primary aldosteronism is associated with cortisol cosecretion. J. Clin. Endocrinol. Metab. 104(8), 3192\u20133202 (2019)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"3095_CR15","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata, M. Stowasser, W.F. Young Jr., The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(5), 1889\u20131916 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"3095_CR16","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1210\/jc.2014-3551","volume":"100","author":"Y Jiang","year":"2015","unstructured":"Y. Jiang, C. Zhang, W. Wang, T. Su, W. Zhou, L. Jiang, W. Zhu, J. Xie, G. Ning, Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism. J. Clin. Endocrinol. Metab. 100(5), 1837\u20131844 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3095_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/cen.12981","volume":"85","author":"Y Jiang","year":"2016","unstructured":"Y. Jiang, C. Zhang, L. Ye, T. Su, W. Zhou, L. Jiang, Y. Zhang, W. Wang, Factors affecting parathyroid hormone levels in different types of primary aldosteronism. Clin. Endocrinol. (Oxf.) 85(2), 267\u2013274 (2016)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"6","key":"3095_CR18","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/cen.13962","volume":"90","author":"L Xiao","year":"2019","unstructured":"L. Xiao, Y. Jiang, C. Zhang, L. Jiang, W. Zhou, T. Su, G. Ning, W. Wang, A novel clinical nomogram to predict bilateral hyperaldosteronism in Chinese patients with primary aldosteronism. Clin. Endocrinol. (Oxf.) 90(6), 781\u2013788 (2019)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"Suppl 1","key":"3095_CR19","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc10-S062","volume":"33","author":"American Diabetes A","year":"2010","unstructured":"American Diabetes A, Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1), S62\u201369 (2010)","journal-title":"Diabetes Care"},{"issue":"8","key":"3095_CR20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1507\/endocrj.EJ13-0060","volume":"60","author":"K Murase","year":"2013","unstructured":"K. Murase, R. Nagaishi, H. Takenoshita, T. Nomiyama, Y. Akehi, T. Yanase, Prevalence and clinical characteristics of primary aldosteronism in Japanese patients with type 2 diabetes mellitus and hypertension. Endocr. J. 60(8), 967\u2013976 (2013)","journal-title":"Endocr. J."},{"issue":"2","key":"3095_CR21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1210\/jc.2005-1733","volume":"91","author":"F Fallo","year":"2006","unstructured":"F. Fallo, F. Veglio, C. Bertello, N. Sonino, P. Della Mea, M. Ermani, F. Rabbia, G. Federspil, P. Mulatero, Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J. Clin. Endocrinol. Metab. 91(2), 454\u2013459 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"3095_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1055\/s-0029-1246189","volume":"42","author":"M Reincke","year":"2010","unstructured":"M. Reincke, C. Meisinger, R. Holle, M. Quinkler, S. Hahner, F. Beuschlein, M. Bidlingmaier, J. Seissler, S. Endres, Participants of the German Conn\u2019s R. Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn\u2019s Registry. Horm. Metab. Res 42(6), 435\u2013439 (2010)","journal-title":"Horm. Metab. Res"},{"key":"3095_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.steroids.2014.08.016","volume":"91","author":"JM Luther","year":"2014","unstructured":"J.M. Luther, Effects of aldosterone on insulin sensitivity and secretion. Steroids 91, 54\u201360 (2014)","journal-title":"Steroids"},{"issue":"10","key":"3095_CR24","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1097\/HJH.0b013e3282861fa4","volume":"25","author":"LM Mosso","year":"2007","unstructured":"L.M. Mosso, C.A. Carvajal, A. Maiz, E.H. Ortiz, C.R. Castillo, R.A. Artigas, C.E. Fardella, A possible association between primary aldosteronism and a lower beta-cell function. J. hypertension 25(10), 2125\u20132130 (2007)","journal-title":"J. hypertension"},{"issue":"10","key":"3095_CR25","first-page":"755","volume":"8","author":"K Shimamoto","year":"1994","unstructured":"K. Shimamoto, M. Shiiki, T. Ise, Y. Miyazaki, K. Higashiura, M. Fukuoka, A. Hirata, A. Masuda, M. Nakagawa, O. Iimura, Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism? J. Hum. Hypertension 8(10), 755\u2013759 (1994)","journal-title":"J. Hum. Hypertension"},{"issue":"5","key":"3095_CR26","doi-asserted-by":"publisher","first-page":"938","DOI":"10.2337\/dc18-1293","volume":"42","author":"Y Akehi","year":"2019","unstructured":"Y. Akehi, T. Yanase, R. Motonaga, H. Umakoshi, M. Tsuiki, Y. Takeda, T. Yoneda, I. Kurihara, H. Itoh, T. Katabami, T. Ichijo, N. Wada, Y. Shibayama, T. Yoshimoto, K. Ashida, Y. Ogawa, J. Kawashima, M. Sone, N. Inagaki, K. Takahashi, M. Fujita, M. Watanabe, Y. Matsuda, H. Kobayashi, H. Shibata, K. Kamemura, M. Otsuki, Y. Fujii, K. Yamamoto, A. Ogo, S. Okamura, S. Miyauchi, T. Fukuoka, S. Izawa, S. Hashimoto, M. Yamada, Y. Yoshikawa, T. Kai, T. Suzuki, T. Kawamura, M. Naruse, Japan Primary Aldosteronism Study G. High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan. Diabetes Care 42(5), 938\u2013945 (2019)","journal-title":"Diabetes Care"},{"issue":"5","key":"3095_CR27","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.119.13922","volume":"75","author":"GK Adler","year":"2020","unstructured":"G.K. Adler, G.R. Murray, A.F. Turcu, H. Nian, C. Yu, C.C. Solorzano, R. Manning, D. Peng, J.M. Luther, Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans. Hypertension 75(5), 1251\u20131259 (2020)","journal-title":"Hypertension"},{"issue":"9548","key":"3095_CR28","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/S0140-6736(06)69700-6","volume":"368","author":"G Danaei","year":"2006","unstructured":"G. Danaei, C.M. Lawes, S. Vander Hoorn, C.J. Murray, M. Ezzati, Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 368(9548), 1651\u20131659 (2006)","journal-title":"Lancet"},{"issue":"22","key":"3095_CR29","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1016\/j.jacc.2019.09.057","volume":"74","author":"GP Rossi","year":"2019","unstructured":"G.P. Rossi, Primary aldosteronism: JACC state-of-the-art review. J. Am. Coll. Cardiol. 74(22), 2799\u20132811 (2019)","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"3095_CR30","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1210\/jc.2016-1002","volume":"101","author":"JJ Joseph","year":"2016","unstructured":"J.J. Joseph, J.B. Echouffo-Tcheugui, R.R. Kalyani, H.C. Yeh, A.G. Bertoni, V.S. Effoe, R. Casanova, M. Sims, A. Correa, W.C. Wu, G.S. Wand, S.H. Golden, Aldosterone, renin, and diabetes mellitus in African Americans: the Jackson heart study. J. Clin. Endocrinol. Metab. 101(4), 1770\u20131778 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"3095_CR31","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1097\/HJH.0000000000001251","volume":"35","author":"M Murata","year":"2017","unstructured":"M. Murata, T. Kitamura, D. Tamada, K. Mukai, S. Kurebayashi, T. Yamamoto, K. Hashimoto, R.D. Hayashi, H. Kouhara, S. Takeiri, Y. Kajimoto, M. Nakao, T. Hamasaki, M. Otsuki, I. Shimomura, Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism. J. Hypertens. 35(5), 1079\u20131085 (2017)","journal-title":"J. Hypertens."},{"issue":"16","key":"3095_CR32","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","volume":"75","author":"Z Xu","year":"2020","unstructured":"Z. Xu, J. Yang, J. Hu, Y. Song, W. He, T. Luo, Q. Cheng, L. Ma, R. Luo, P.J. Fuller, J. Cai, Q. Li, S. Yang, Chongqing primary aldosteronism study G primary aldosteronism in patients in china with recently detected hypertension. J. Am. Coll. Cardiol. 75(16), 1913\u20131922 (2020)","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03095-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03095-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03095-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T15:33:40Z","timestamp":1660750420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03095-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["3095"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03095-8","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"assertion":[{"value":"23 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}